Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer.
Article in American Journal of Clinical Oncology (July 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in American Journal of Clinical Oncology (July 2024)
Article in Biomedicines (May 2024)
Article in Genes (May 2024)